GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Net Issuance of Debt

G.Barekat Pharm (XTEH:BRKT1) Net Issuance of Debt : IRR3,146,982 Mil (TTM As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. G.Barekat Pharm's net issuance of debt for the six months ended in Mar. 2017 was IRR3,146,982 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2017 was IRR3,146,982 Mil.


G.Barekat Pharm Net Issuance of Debt Historical Data

The historical data trend for G.Barekat Pharm's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Net Issuance of Debt Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Net Issuance of Debt
1,621,354.00 3,146,982.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Net Issuance of Debt 1,621,354.00 3,146,982.00

G.Barekat Pharm Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2017 was IRR3,146,982 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G.Barekat Pharm Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines